Discovery of “unconventional” immune response opens new avenue in TB vaccine development

FHS
July 16, 2024
3:29 am

An “unconventional” immune response now identified by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) is a potential new pathway for developing new vaccines for tuberculosis (TB), according to a new publication.

BioAge files for IPO, riding momentum for weight loss drugs

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 4, 2024

Twitter data reveals demographic insights into COVID-19 guideline compliance

A study in Scientific Reports analyzed Twitter data to identify demographic factors influencing adherence to COVID-19 public health guidelines, revealing significant variations in social mobility

January 16, 2024

What the public might learn from Kate Middleton, the latest ‘famous patient’

There was a time when the last thing a celebrity would do would be to go public with details of a major illness. After all,

March 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.